Browse studies

Find your next paid study

27,288 recruiting studies available now

Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency: the PERT-AP Trial

This study aims to evaluate if a 6-month course of pancrelipase (CREON) treatment improves symptoms of exocrine pancreatic insufficiency (EPI) after an attack …

Exocrine Pancreatic Insufficiency

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Ohio State UniversityNCT06477159

Phase 1

Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and…

WomenAgingMenopause

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of Missouri-ColumbiaNCT07674680

Observational

Multimodal Investigation of Neural Plasticity Induced by Non-invasive Brain Stimulation

This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in cognitively intact older adults (healthy co…

Mild Cognitive Impairment

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT06453980

Long-term Oncologic Safety of Nipple Sparing Mastectomy in Women With High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes

Patients with a germline pathogenic variant (GPV) in high-penetrance breast cancer susceptibility genes who are considering risk reducing mastectomy (RRM) ofte…

Breast Cancer Surgery

Estimated

~$10 – $750

Actual pay is set by the research site.

Sir Mortimer B. Davis - Jewish General HospitalNCT06888388

Observational

Sensor Ankle Brace for Special Operations Rehabilitation - Phase 2

The primary purpose of this study overall is to validate a modified version of a commercially available ankle brace. Inertial measurement unit sensors will be …

GaitBalanceBiomechanical Data+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT07776223

A Prospective Longitudinal Outcomes Registry of Complex Regional Pain Syndrome Type 1 (CRPS-1) in Participants Treated With Neridronate in the CRPS-RISE Trial and/or Open-Label Extension (OLE)

The goal of this observational study is to learn about how well neridronate keeps working in the months after treatment. For 12 or up to 24 months while the re…

Complex Regional Pain Syndrome I (CRPS I)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Ambros Therapeutics, Inc.NCT07811362

Phase 1

A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation

The objectives of this study are to test the preliminary safety and efficacy of a two-day peri-operative course of treprostinil in reducing ischemia-reperfusio…

Ischemia Reperfusion InjuryDelayed Graft Function

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Rhode Island HospitalNCT04005469

Intermuscular Coherence: A Biomarker for Early Diagnosis and Follow-up of ALS

The specific aims of this study are to: 1. Determine if a painless and quick measurement of muscle activity using surface electrodes can help with the diagnos…

Amyotrophic Lateral Sclerosis

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ChicagoNCT05104710

Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability…

CopdSmokingTobacco Use

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT04722835

SPIROMICS Study of Early COPD Progression (SOURCE)

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk indi…

COPD, Early-Onset

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Massachusetts, WorcesterNCT05033990

Phase 3

A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Prophylaxis in Patients With Type 3 Von Willebrand Disease

This is a Phase III, multicenter, open-label clinical study designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab pro…

Von Willebrand Disease, Type 3

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Hoffmann-La RocheNCT06998524

Phase 2

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

This is a prospective radiation dose-finding, phase 2 expansion study of the Triple Negative (TN) cohort of the multicenter randomized study P-RAD (A Randomize…

Breast CancerTriple Negative Breast Cancer (TNBC)HER2-Negative Breast Carcinoma+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT07276880